News > OWL Metabolomics will present an overview of the role of metabolomics in NASH Clinical Trials in collaboration with its partner Cerba Research

Events

OWL Metabolomics will present an overview of the role of metabolomics in NASH Clinical Trials in collaboration with its partner Cerba Research

OWL Metabolomics will present an overview of the role of metabolomics in NASH Clinical Trials in collaboration with its partner Cerba Research

 

OWL Metabolomics will participate in a webinar together with its partner Cerba Research highlighting the role of metabolomics in phase 2 and 3 NASH clinical trials.

 

OWL Metabolomics´ CSO, Dr. Pablo Ortiz, will present an overview of the applications of metabolomics, with special focus on lipidomics, in NASH drug development projects. The presentation will focus on the impact of the placebo effect in NASH clinical trials and how metabolomics can help detect the true effect of the drug without being hidden by the placebo response. Our expect will also present the power of the technology for monitoring drug activity and dose-dependent changes, as well as the evaluation of cardiovascular risk through lipoprotein fractionation.

The webinar titled In Light of NASH: How to Optimize Your Liver Biopsy Results will take place next 15th of September at 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central).

In this session, three experts will highlight possible ways to get the most out of liver biopsies (discuss available stainings of liver biopsies for diagnosing NASH, how alternative and innovative imaging can facilitate pathologists’ reading of the samples) and moreover, provide an overview of metabolomics in NASH clinical trials.

To register please visit:

https://xtalks.com/webinars/in-light-of-nash-how-to-optimize-your-liver-biopsy-results/

OWL is a trading name of
ONE WAY LIVER, S.L
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
Phone:
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 11/29/2021

With the collaboration of: